Back to Search Start Over

Aortic Valve Sclerosis in High-Risk Coronary Artery Disease Patients.

Authors :
Myasoedova VA
Genovese S
Cavallotti L
Bonomi A
Chiesa M
Campodonico J
Rondinelli M
Cosentino N
Baldassarre D
Veglia F
Pepi M
Alamanni F
Colombo GI
Marenzi G
Poggio P
Source :
Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2021 Jul 27; Vol. 8, pp. 711899. Date of Electronic Publication: 2021 Jul 27 (Print Publication: 2021).
Publication Year :
2021

Abstract

Background: Current knowledge regarding the relationship between aortic valve sclerosis (AVSc), cardiovascular risk factors, and mortality in patients with known coronary artery disease (CAD) is still unclear. The present study aimed at investigating the prevalence of AVSc as well as its association with long-term all-cause mortality in high-risk CAD patients that has never been explored in large cohorts thus far. Methods and Results: In this retrospective and observational cohort study we enrolled high-risk CAD patients, hospitalized at Centro Cardiologico Monzino (CCM), Milan, Italy, between January 2006 and December 2016. The morphology and function of the aortic valve were assessed from the recorded echocardiographic images to evaluate the presence of AVSc, defined as a non-uniform thickening of the aortic leaflets with no consequences on hemodynamics. Data on 5-year all-cause mortality was retrieved from a Regional database. Of the 5,489 patients initially screened, 4,938 (mean age 67 ± 11 years, 3,954 [80%] men) were enrolled in the study. In the overall population, AVSc was detected in 2,138 (43%) patients. Multivariable LASSO regression revealed that age, female gender, diabetes mellitus, previous MI, and left ventricular ejection fraction were independently associated with AVSc. All-cause mortality (adjusted hazard ratio: 1.29, 95%CI: 1.05-1.58) was significantly higher in AVSc than in non-AVSc patients. Conclusions: AVSc is frequently detected in high-risk CAD patients and is associated with long-term mortality. Our findings corroborate the hypothesis that AVSc is an underestimated marker of systemic cardiovascular risk. Thus, AVSc detection may be used to improve long-term risk stratification of high-risk CAD patients.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Myasoedova, Genovese, Cavallotti, Bonomi, Chiesa, Campodonico, Rondinelli, Cosentino, Baldassarre, Veglia, Pepi, Alamanni, Colombo, Marenzi and Poggio.)

Details

Language :
English
ISSN :
2297-055X
Volume :
8
Database :
MEDLINE
Journal :
Frontiers in cardiovascular medicine
Publication Type :
Academic Journal
Accession number :
34386534
Full Text :
https://doi.org/10.3389/fcvm.2021.711899